Tengjun Biotechnology Corp. Annual Operating Income (Loss) in USD from 2011 to 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Tengjun Biotechnology Corp. quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2022.
  • Tengjun Biotechnology Corp. Operating Income (Loss) for the quarter ending June 30, 2023 was -$428K, a 109% decline year-over-year.
  • Tengjun Biotechnology Corp. annual Operating Income (Loss) for 2022 was $16.1M.
  • Tengjun Biotechnology Corp. annual Operating Income (Loss) for 2021 was -$738K, a 10.8% decline from 2020.
  • Tengjun Biotechnology Corp. annual Operating Income (Loss) for 2020 was -$666K, a 1588% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $16.1M* +$16.8M Jan 1, 2022 Dec 31, 2022 10-K 2023-04-17
2021 -$738K -$71.8K -10.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-17
2020 -$666K -$627K -1588% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 -$39.5K -$9.6K -32.1% Jan 1, 2019 Dec 31, 2019 10-K 2021-02-17
2018 -$29.9K +$2.59K +7.97% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-28
2017 -$32.5K +$4.34K +11.8% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-08
2016 -$36.8K Jan 1, 2016 Dec 31, 2016 10-K 2018-03-07
2011 -$24.5K Jan 1, 2011 Dec 31, 2011 10-K 2012-02-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.